Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Glycobiology Conference 2019

Glycobiology Conference 2019

Conference Series LLC Ltd feels great pleasure to invite you all to attend 6th International Conference on Glycobiology & Glycoproteomics, (Glycobiology Conference 2019) is going to be held in Chicago, USA on July 31- August 01, 2019. The conference is going to bring together glycobiologists, scientists, molecular biologists, biochemists, industrial experts, delegates, sponsors and related exhibitors from all around the world to the marvelous city of Chicago, USA. The conference theme focuses on "Facts, fictions, and future of glycos: A closure look".

Glycobiology in wider aspects includes the study of structure, function, and biology of carbohydrates, biosynthesis related to sugars and saccharides. Recently Glycobiology is fast emerging as a preliminary field of interest for biomedical and biomolecular research around the world. It is the growing field in the area of research related to biomolecules which mainly includes the study of different metabolic pathways, along with the prediction of the various structures of sugar-related biomolecules and many others etc.

Why to attend???

Various members from all around the globe have focused their research and expertise on learning more and more about various biomolecules and use of Glycobiology, this is a best chance to meet the global participants in the wider arena of Biochemistry and Glycobiology, to share information, meeting with current and expert researchers and receive name recognition in this two day premier event. 

Target Audience:


Scientists and Researchers

Biochemistry Associations and Societies


Business Entrepreneurs

Biochemistry Experts

Medical Colleges

Research Training Institutes

Pharma Companies

Conference Series LLC Ltd invites all the participants across the globe to attend the 6th International Conference on Glycobiology & Glycoproteomics during July 31- August 01, 2019 in ChicagoUSA.

Glycobiology Conference 2019 is designed to meet all renowned and eminent speakers, research experts from all around the globe with delegates, exhibitors, and industry experts and workshop symposiums.

For more details:

Details of Glycobiology Conference 2019 in Chicago:

Conference Series LLC Ltd is organizing Glycobiology and Glycoproteomics in 2019 in Chicago, USA. We organize Biochemistry Meetings in the fields related to Enzymology, Epigenetics, Protein Engineering, Antibody Engineering, and Industrial Biochemistry and in Biology like Structural, Molecular, Cell, Plant and Animal.


Conference Name



Glycobiology Conference 2019

Chicago, USA

July 31- August 01, 2019



Track: 1 Glycobiology and Glycochemistry

It involves the study of everything related to the structure, biosynthesis, and biology of sugars and saccharides drawing from simple organic chemistry, molecular and cellular biologyenzymology and related domains. Like amino acids and nucleic acids, sugars are the major contributors in nature many natural products contain oligosaccharides that are important for their biological and biochemical activity and carbohydrates have major roles in a wider range of biological processes including signal transduction mechanisms and immune responses. So the study of glycan structures is also complicated by the lack of a proper and direct template for their biosynthesis, contrary to the case with amino acids and proteins.

Track: 2 Molecular Glycoscience and Monosaccharides

Glycoscience has become a vital, expanding and important extension of modern molecular biology and biomedicine in today’s era. The wider complexity of glycosylated and related structures is only paralleled to their utility. Discovering carbohydrate and glycan antigens as cancer biomarkers or even abnormal glycation pathways in metabolic disorders such as diabetes inhibited the importance of the expansion of glycoscience in a future, as a way of representing new biomarkers and therapeutic targets in disease. The final goal is to enhance research capabilities on glycosciences and provide ground to present and future emerging discoveries in glycosciences into new clinical applications and diagnostics.

Track: 3 Proteoglycan and Sialic acid

Proteoglycans are more than 95% carbohydrate by weight. Proteoglycan helps to provide us with the idea to the molecule's various chemical compositions. As proteo refers to protein, while glycan represents sugar or a group of sugars, so proteoglycan is a long polysaccharide chain covalently attached to a protein. The protein component of proteoglycans is synthesized by ribosomes and mainly translocated into the lumen of the rough endoplasmic reticulum. Sialic acid is a generic term for the N- or O-substituted derivatives of neuraminic acid, a monosaccharide with a nine-carbon backbone and are found widely distributed in animal tissues and to a lesser extent in some other organisms, ranging from fungi, plants, yeasts, and bacteria, mostly in glycoproteins and gangliosides.

Track: 4 Glycoproteomics Analysis

Glycoproteomics is emerging and booming as an important sub-discipline of proteomics, focusing on the role of protein glycosylation in various biological processes. It focusses on the branch of proteomics that identifies, summarizes, and characterizes proteins containing carbohydrates as a post-translational modification by using Mass spectrometry which is commonly and widely used to identify the sugar moieties attached. Glycomics is the comprehensive study of glycomes the entire complement of sugars, whether free or present in more complex molecules of an organism including genetic, pathologic, physiologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology.

Track: 5 Protein engineering and Glycoimmunology 

Carbohydrates were very important in the early history of immunology in describing the identity of antigens which are recognized by antibodies. So the ability of these antibodies to uniquely recognize glycans and carbohydrate-related molecules was exploited in studies defining the size of the antigen-binding site. Numerous carbohydrate-binding proteins, or lectins, have been identified on the surfaces of immune cells which intensify the importance of carbohydrates in both innate and adaptive immune responses in the development of modern vaccines and immunological therapeutics. Recently glycobiologists and immunologists are now collaborating extensively to explore this crucial field in the area of immunobiology.

Track: 6 Glycolipids and Glycopeptides

Glycolipids are limited in fractions but known to be major and important contributors to glycoconjugates in all areas of life. The structural diversity of glycolipids is exceptional, as different types of lipids are glycosylated in almost every forms of life like animals, plants, and bacteria. Their role basically is to maintain the stability of the membrane and to facilitate other cellular recognition. They act as glycan-carriers in the membranes of photosynthetic structures in, algae, plants, and bacteria.

Glycopeptides are basically peptides that contain carbohydrate moieties generally glycan’s which are covalently attached to the side chains of the amino acid residues that constitute the peptide. These include a class of drugs of microbial origin that are composed of glycosylated cyclic or polycyclic non-ribosomal peptides.

Track: 7 Glycopathology: Glycans in Cancer

Carbohydrates are basically considered as major sources of structural materials and energy for living organisms. Recent modern research’s in this area has focused mainly on simple basic sugars and homopolysaccharides such as starch, cellulose, glycogen, and chitin. During the last few decades, the researchers have shifted their focus on complex forms like carbohydrates, especially proteoglycans, glycolipids and glycoproteins which are collectively referred to as glycoconjugates that shows the potential of recognition markers in the biological system which also relates to other biomedical and clinical fields. The roles of glycans and glycoconjugates in cancer have been emphasized because a small alteration in glycosylation can tremendously regulate the whole pathway and mechanisms of cancer, which leads to an indication as a biomarker development leading to various therapeutics development in cancer research.

Track: 8 Glyconeurobiology: Glycans in Neuroscience

Carbohydrate-rich molecules like including glycolipids, glycoproteins, and proteoglycans in the nervous system have important roles during development, regeneration and synaptic plasticity. The structural diversity of the carbohydrate moieties renders them ideally suited as stage-specific biomarkers for various cell types leading to mediate interactions between recognition molecules, thereby contributing to the formation of a complex molecular framework at the cell surface and in the extracellular matrix of the cell. The exceptional structural diversity of glycan chains and related moieties allows for immense advanced possibilities that can lead to cell interactions along with cell-matrix interactions.


Track: 9 Glycoconjugates and Glycomics and Metabolomics

Glycomics parallel to proteomics and genomics is the systematic study of all the glycan structures of a given cell type or organism and is a subset of glycobiology. Sugars are generally linked to other types of the biological molecule to form glycoconjugates. The various enzymatic process of glycosylation creates sugars or saccharides linked to themselves and to other molecules by the glycosidic bond, finally producing glycans. Proteoglycans, glycoproteins, and glycolipids are the most abundant glycoconjugates found in mammalian cells. Glycoconjugates have been shown to be important and play a prominent role in cell-cell interactions due to the presence on the cell surface of various glycan binding receptors in addition to the glycoconjugates themselves.

Track: 10 Mass Spectrometry in Glycobiology Research

Mass spectrometry (MS) is a vital analytical technique that ionizes chemical species and sorts the ions based on their mass-to-charge ratio. A mass spectrum is a plot of the ion signal as a function of the mass-to-charge ratio during experimental analysis. These spectra are then used to determine the elemental or isotopic signature of a sample for observations, the masses of particles and of various molecules, and to clarify the chemical structures of desired molecules, such as biomolecules, glycopeptides, and other chemical compounds.

Track: 11 Glycans in Vaccine Development

Recent technological advances in the field of glycobiology and glycochemistry are showing the way for a new era in carbohydrate related vaccine design. This is enabling a tremendous efficiency in the synthesis, identification, and evaluation of unique glycan epitopes found on a number of pathogens and cancerous cells. Glycans and related carbohydrate molecules are at the center of many disorders and diseases opening the possibility of exploiting them for therapeutic and diagnostic purposes. There are various biochemical pathways and diseases in which carbohydrates are complexly involved.

Track: 12 Glycans in Diseases and Therapeutics

Glyco-epitope diversity enhances the role of glycan’s and is now considered essential for life, both under normal and pathological conditions. The vital role of glycans in the research and development of diseases and the possible therapeutic use of this class of molecules by describing how the interaction of glycans with growth factors, extracellular proteases, growth factor binding proteins, protease inhibitors, chemokine’s, morphogens, and adhesive proteins regulates inflammation, infection, atherosclerosis,  cancer, thrombosis, and embryonic stem cell biology.

Track: 13 Recent Advances in Glycobiology

Generally, glycans are vital components of many biotherapeutic agents, differing from natural products to molecules based on various rational designs to recombinant glycoproteins and glycoconjugates. The glycan components of these agents can be important determinants of their biological activity and therapeutic efficacy. Modern patenting of new therapeutics typically requires clarifications of the composition of matter in the claimed molecule for approval. Many remarkable advances can be seen in the areas of imaging, structure prediction technologies, and advancement of hybrid methods to understand the structure and function of carbohydrates and proteins.

Market Analysis

Market Report:

Glycobiology Conference 2019 welcomes attendees, presenters, and exhibitors from all over the world to Toronto, Canada. We are delighted to invite you all to attend and register for the “6th International Conference on Glycobiology & Glycoproteomics which is going to be held during July 31-August 01, 2019 in Chicago, USA.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Glycobiology Conference 2019 where you will be sure to have a meaningful experience with scholars from around the world. All the members of the Glycobiology Conference 2019 organizing committee look forward to meeting you in Chicago, USA.

Importance & Scope:

Most aspects of glycobiology depend on successful researches. Glycobiology Conference 2019 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Glycobiology leading way to the unraveled. It also provides the chance for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of glycobiology.

Glycobiology Conference 2019 is an essential platform for presenting research about marketing, exchanging ideas about it and thus, contributes to the dissemination of knowledge for the benefit of both the academia and business. Glycobiology is where the future intersects. This event brings together eminent researchers and associates to explore the emerging field. We bring together knowledge, creative, and technology leaders from the biology industry for the most current and relevant discussions.

Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019) and is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, which is a positive sign in the field of modern era research. This report describes the global Glycobiology market by application, end users, products, and geographies. According to the World Bank and agencies, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S.A, overall funding for research and development was about $291.77 billion in 2001, which drastically increased to $428.94 billion in 2010. A number of factors such as increasing focus of government and private funding for Glycobiology and proteomics research and huge investment by pharmaceutical and research companies are the key promoters for the growth of this market. On the basis of the product, the market is distributed into enzymes, instruments, diagnostic kits, and chemical reagents and the enzymes segment like glycosidases, neuraminidases, sialyltransferases, glycosyltransferases, and other enzymes but glycosidases is expected to the major contributor of the Glycobiology research with the largest shares in R&D activities for the development of novel drugs and therapies.

Geographic analysis reveals that North America accounted for the largest share of the global glycomics market in 2014, due to increased funding for proteomics and glycomics research. For instance, in August 2013, the National Institutes of Health (NIH) provided $5.5 million to the National Center for Functional Glycomics (NCFG) for research into the identification of glycans and complex carbohydrates using glycan microarrays. Similarly, in 2011, the University Of Nevada School Of Medicine received $10 million for glycobiology research from NIH.

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S). 

Conference Highlights

• Glycobiology and Glycochemistry

• Molecular Glycoscience and Monosaccharides

• Proteoglycan and Sialic acid

• Glycoproteomics Analysis

• Glycoimmunology

• Glycolipids and Glycopeptides

• Glycopathology: Glycans in Cancer

• Glyconeurobiology: Glycans in Neuroscience

• Glycoconjugates and Glycomics and Metabolomics

• Mass Spectrometry in Glycobiology Research

• Glycans in Vaccine Development

• Glycans in Diseases and Therapeutics

• Recent Advances in Glycobiology

Why to attend???

This conference will be focusing on all the major aspects in the fields of Glycobiology and its related research which is going across the world. It would be beneficial for all the students, research professionals whoever willing to enter into research or doing innovative research to the respective fields. As bringing the major research to the market and making it to the utility are the major focus for all the companies, this conference would be an opportunity for the people in the respective fields. Meeting with members from around the world focused on learning about biological research and growing market, this is your single best opportunity to reach the largest assemblage of participants from the scientific community. Conduct demonstrations, distribute information, meet with current and potential customers, and make a splash with a new product line, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Glycobiology growing market are hallmarks of this conference.

Major Glycobiology Associations around the Globe

Royal Society of Chemistry Carbohydrate Group (UK)

Mizutani Foundation for Glycoscience

The Japanese Society of Carbohydrate Research

Copenhagen Center for Glycomics

Alberta Glycomics Centre (Canada)

Center for Glycobiology (Israel)

International Society of Rare Sugars

ISHAS: International Society for Hyaluronan Sciences

NCGG: National Center for Glycomics and Glycoproteomics

Laboratory of Carbohydrate Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Science

Complex Carbohydrate Research Center (USA)

Consortium for Functional Glycomics (CFG) (USA)

Glycobiology Research and Training Center (USA)

Oxford Glycobiology Institute

Centre for Glycobiology, University of Liverpool

IBS: Institut de Biologie Structurale

 Glycoscience Team, National Centre for Biomedical Engineering Science, National University of Ireland, Galway

Major Glycobiology Related Associations 

Glycosciences Laboratory

Oxford Glycobiology Institute

Glycobiology Group

Glycotechnology Core Resource

Glycobiology Research and Training Center

Glycomics Center

Resource for Integrated Glycotechnology

Institute of Molecular Biomembrane and Glycobiology

To Collaborate Scientific Professionals around the World

Conference Date July 31-August 01, 2019

For Sponsors & Exhibitors

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by